Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Novolizer vs Turbuhaler in Chinese Mild to Moderate Asthma
NCT01269437Phase 3Unknown
- Sponsor
- NovaMed Pharmaceuticals
- Start
- Dec 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide in asthma (2 arms), sponsored by NovaMed Pharmaceuticals. Primary endpoint: Morning Peak Expiratory Flow at 12 weeks. Status: unknown.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01269437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269437.